The Magazine for Sleep Professionals
Sunday, April 26, 2026
As part of the U.S. Food and Drug Administration’s continued commitment to protect and promote the public health, the agency is alerting patients and healthcare providers of an emerging safety issue involving Philips Respironics’ DreamStation 2 Continuous Positive Airway Pressure (CPAP) machines used for treatment of obstructive sleep apnea. The […]
By Amber Carmen Arroyo, PhD Continuous positive airway pressure (CPAP) therapy is the first line and is typically considered the gold standard treatment for obstructive sleep apnea (OSA).1 Yet, adherence to CPAP has been consistently low since CPAP’s inception, generally ranging from just 30 to 60%.2 Despite exponential growth in […]
Consistently sleeping less than five hours a night might raise the risk of developing depressive symptoms, according to a new genetic study led by UCL researchers. Historically, poor sleep has been seen as a side effect of mental ill health, but this study found that the link between sleep and […]
Jazz Pharmaceuticals plc announced that the Company and its partners will present 14 abstracts from across its sleep medicine portfolio, including two oral presentations, at the 17th annual World Sleep 2023 Congress, held October 20-25 in Rio de Janeiro, Brazil. The oral presentations include findings from the real-world TENOR study, […]
Kingman Strohl, MD Obstructive sleep apnea (OSA) is effectively managed by positive airway pressure (PAP) applied to the nose and/or mouth. The principle of PAP is to inflate the critical region of closure in the upper airway, usually at the base of the tongue or the uvula. The effective property […]
Jazz Pharmaceuticals plc announced that six abstracts presenting data from across its sleep medicine portfolio were featured at the 36th annual Psych Congress, held September 6-10, 2023. One of the accepted abstracts provided a comprehensive review of clinical data that assessed the impact of oxybate on sleep quality, sleep architecture and […]
By Regina Patrick, RPSGT, RST Obstructive Sleep Apnea and Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS) is a disorder in which many small fluid-filled sacs (i.e., cysts) develop on a woman’s ovaries and the ovaries produce high levels of male sex hormones (i.e., androgens). PCOS is also associated with insulin […]
A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil shows that the telomere shortening that naturally occurs with aging and is accelerated by OSA can be mitigated by the use of continuous positive airway pressure (CPAP). Telomeres are structures made from DNA sequences and proteins found […]
Daytime fatigue, psychological problems, and even traffic incidents are all linked to sleep disorders, prompting specialists to investigate work efficiency declines among up to 20% of young Australians impacted by sleep disorders. The recent research conducted by Flinders University utilized information from the West Australian longitudinal Raine Study Generation 2 […]
Takeda announced that data from the Phase 2 study of orexin receptor 2 (OX2R) agonist TAK-994 in patients with narcolepsy type 1 (NT1) was published in The New England Journal of Medicine. These data represent the first-ever clinical data to be published of an oral orexin agonist in NT1. The […]
